Publications by authors named "Mark Preston"

Claim this Profile
G
Gemcitabine intravesical system plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with MIBC: primary analysis and biomarker results of SunRISe-4.
Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, Bernardo Herrera-Imbroda, Rohan Garje, Mark A Preston

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial.
Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, Bernardo Herrera-Imbroda, Rohan Garje, Mark A Preston

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of [F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy.
Thomas S C Ng, Mofei Liu, Matthew Robertson, Arda Könik, Su Chun Cheng, Mark Preston

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies.
Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Jeffrey Howard, Mark A Preston

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients.
Rana R McKay, Ashley E Ross, Mark A Preston, Justin R Gregg, Simpa S Salami

Future Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer.
Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard, Mark Preston

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancer.
Zhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, J Bailey Vaselkiv, Travis Gerke, Mark A Preston

Am J Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.
Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard, Mark A Preston

BJU Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer.
Mark A Preston, Ramin Ebrahimi, Agnes Hong, Priyanka Bobbili, Raj Desai

Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
William Paul Skelton, Jack Masur, Jonathan Thomas, Parvaneh Fallah, Rohit K Jain, Mark A Preston

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
Florian Rumpf, Anna Plym, Jane B Vaselkiv, Kathryn L Penney, Mark A Preston

J Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial.
Rana R McKay, Wanling Xie, Xiaoyu Yang, Andres Acosta, Dana Rathkopf, Mark A Preston

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Thomas W Flaig, Philippe E Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Mark A Preston

J Natl Compr Canc Netw· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goal-Related Feedback Seeking, Receiving Goal-Related Feedback, and Internal Work Motivation: A Two-Sample Mediation Study Using Human Service Case Managers.
Mark Preston

J Evid Based Soc Work (2019)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study.
Sigrid V Carlsson, Mark A Preston, Andrew Vickers, Deepak Malhotra, Behfar Ehdaie

Appl Clin Inform· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool.
Sigrid V Carlsson, Mark Preston, Andrew Vickers, Deepak Malhotra, Behfar Ehdaie

Appl Clin Inform· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Delayed Testosterone Recovery in Patients with Prostate Cancer.
Mark A Preston, Agnes Hong, Robert Dufour, Jessica R Marden, Noam Y Kirson

Eur Urol Open Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer screening in African American men: a review of the evidence.
Kevin H Kensler, Roman Johnson, Faith Morley, Mohamed Albrair, Barbra A Dickerman, Mark A Preston

J Natl Cancer Inst· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer.
Vincent D'Andrea, Zhiyu Jason Qian, Kendrick Yim, Jillian Egan, Christopher J Magnani, Mark Preston

Urol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.
Zhiyu Qian, Jamie Ye, David F Friedlander, Mara Koelker, Muhieddine Labban, Mark A Preston

Can J Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
Shalender Bhasin, Thomas G Travison, Karol M Pencina, Michael O'Leary, Glenn R Cunningham, Mark A Preston

JAMA Netw Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Patient-Centered Outcomes and Equity in Clinical Trials for BCG-Unresponsive Nonmuscle Invasive Bladder Cancer.
Thomas J Hwang, Benjamin J Davies, Mark A Preston

JAMA Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Kendrick Yim, Kevin Melnick, Sarah L Mott, Filipe L F Carvalho, Affan Zafar, Mark A Preston

Urol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder Cancer.
Vincent D D'Andrea, Kevin Melnick, Kendrick Yim, John Ernandez, Nnamdi Onochie, Mark A Preston

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes.
Irmina Maria Michalek, Rebecca E Graff, Alejandro Sanchez, Toni K Choueiri, Eunyoung Cho, Mark A Preston

Acta Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis